🕵️ Charles River Laboratories International, Inc. ($CRL)
SEC insider & ownership activity, last 12 months · CIK 1100682 · every row links its SEC filing
Over the last 12 months insiders sold $42.7M against $4K of open-market buying. James C. Foster sold $34.8M through a 10b5-1 trading plan in 3 lots (Jun–Aug). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $4K (1 lots) · 7 sellers, $42.7M (19 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| James C. Foster | 0 | – | 3 | $34.8M | Aug 25, 2026 |
| Shannon M. Parisotto | 0 | – | 3 | $3.0M | Aug 19, 2026 |
| Girshick Birgit | 0 | – | 1 | $1.8M | Aug 11, 2026 |
| Knell Michael Gunnar | 0 | – | 9 | $1.7M | Aug 6, 2026 |
| Victoria L. Creamer | 0 | – | 1 | $1.1M | Aug 6, 2026 |
| Nancy C. Andrews | 0 | – | 1 | $163K | Aug 18, 2026 |
| Joseph W. Laplume | 1 | $4K | 1 | $65K | Mar 3, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 10.2% | 13G | Sep 8, 2026 | filing ↗ | |
| Abigail P. Johnson | 10.2% | 13G | Sep 8, 2026 | filing ↗ | |
| Vanguard Capital Management | 7.4% | 13G | Apr 29, 2026 | filing ↗ | |
| BlackRock, Inc. | 6.9% | 13G | Apr 17, 2025 | filing ↗ | |
| Invesco Ltd. | 6.2% | 13G | Aug 13, 2026 | filing ↗ | |
| Wellington Management Company LLP | 5.7% | 13G | Nov 12, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| James C. Foster | $10.1M | Aug 25, 2026 | filing ↗ |
| Shannon M. Parisotto | $600K | Aug 19, 2026 | filing ↗ |
| Nancy C. Andrews | $163K | Aug 18, 2026 | filing ↗ |
| Shannon M. Parisotto | $1.0M | Aug 11, 2026 | filing ↗ |
| Girshick Birgit | $1.8M | Aug 11, 2026 | filing ↗ |
| James C. Foster | $7.9M | Aug 10, 2026 | filing ↗ |
| Victoria Creamer | $1.1M | Aug 6, 2026 | filing ↗ |
| Michael Knell | $1.7M | Aug 6, 2026 | filing ↗ |
| Shannon M. Parisotto | $1.3M | Aug 5, 2026 | filing ↗ |
| James C. Foster | $16.9M | Jun 29, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 18, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 18, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 3, 2025 | filing ↗ |
| Other events (8.01) | Nov 14, 2025 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 12, 2025 | filing ↗ |